These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28665782)

  • 1. Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.
    Kaneko MK; Kunita A; Yamada S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Ogasawara S; Ohishi T; Abe S; Itai S; Harada H; Kawada M; Nishioka Y; Fukayama M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):157-162. PubMed ID: 28665782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.
    Ogasawara S; Kaneko MK; Yamada S; Honma R; Nakamura T; Saidoh N; Yanaka M; Yoshida K; Fujii Y; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Apr; 36(2):50-56. PubMed ID: 28384052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts.
    Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cancer-specific anti-podocalyxin monoclonal antibody (60-mG
    Kaneko MK; Ohishi T; Kawada M; Kato Y
    Biochem Biophys Rep; 2020 Dec; 24():100826. PubMed ID: 33088928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.
    Itai S; Ohishi T; Kaneko MK; Yamada S; Abe S; Nakamura T; Yanaka M; Chang YW; Ohba SI; Nishioka Y; Kawada M; Harada H; Kato Y
    Oncotarget; 2018 Apr; 9(32):22480-22497. PubMed ID: 29854293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas.
    Itai S; Yamada S; Kaneko MK; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Oct; 36(5):220-223. PubMed ID: 28873000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
    Kaneko MK; Nakamura T; Kunita A; Fukayama M; Abe S; Nishioka Y; Yamada S; Yanaka M; Saidoh N; Yoshida K; Fujii Y; Ogasawara S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):104-112. PubMed ID: 28504613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 47-mG
    Kaneko MK; Itai S; Yamada S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2018 Jun; 37(3):158-161. PubMed ID: 29630446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope Mapping of a Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (PcMab-60) Using Enzyme-Linked Immunosorbent Assay and Surface Plasmon Resonance.
    Asano T; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):227-232. PubMed ID: 34678093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Podocalyxin Monoclonal Antibody 47-mG
    Yamada S; Itai S; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):91-94. PubMed ID: 29649375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin.
    Canals Hernaez D; Hughes MR; Dean P; Bergqvist P; Samudio I; Blixt O; Wiedemeyer K; Li Y; Bond C; Cruz E; Köbel M; Gilks B; Roskelley CD; McNagny KM
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity.
    Kaneko MK; Yamada S; Nakamura T; Abe S; Nishioka Y; Kunita A; Fukayama M; Fujii Y; Ogasawara S; Kato Y
    Cancer Med; 2017 Apr; 6(4):768-777. PubMed ID: 28332312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy.
    Snyder KA; Hughes MR; Hedberg B; Brandon J; Hernaez DC; Bergqvist P; Cruz F; Po K; Graves ML; Turvey ME; Nielsen JS; Wilkins JA; McColl SR; Babcook JS; Roskelley CD; McNagny KM
    Breast Cancer Res; 2015 Mar; 17(1):46. PubMed ID: 25887862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
    Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y
    Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Antihuman Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H
    Kato Y; Ohishi T; Takei J; Nakamura T; Kawada M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2020 Aug; 39(4):135-139. PubMed ID: 32644843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel antagonist anti-cMet antibody with antitumor activities targeting both ligand-dependent and ligand-independent c-Met receptors.
    Gonzalez A; Broussas M; Beau-Larvor C; Haeuw JF; Boute N; Robert A; Champion T; Beck A; Bailly C; Corvaïa N; Goetsch L
    Int J Cancer; 2016 Oct; 139(8):1851-63. PubMed ID: 27144973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma.
    Funahashi SI; Kawai S; Fujii E; Taniguchi K; Nakano K; Ishikawa S; Aburatani H; Suzuki M
    J Biochem; 2018 Dec; 164(6):471-481. PubMed ID: 30239818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
    Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of critical epitope of PcMab-47 against human podocalyxin.
    Itai S; Yamada S; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2018 Jul; 14():78-82. PubMed ID: 29872738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
    Lázaro-Gorines R; Ruiz-de-la-Herrán J; Navarro R; Sanz L; Álvarez-Vallina L; Martínez-Del-Pozo A; Gavilanes JG; Lacadena J
    Sci Rep; 2019 Aug; 9(1):11680. PubMed ID: 31406218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.